CXCR4 Has a CXCL12-Independent Essential Role in MLL-AF9 Driven Acute Myeloid Leukemia

被引：0
|
作者：
Ramakrishnan, Ramprasad [1 ]
Pena-Martinez, Pablo [1 ]
Agarwal, Puneet [2 ]
Hogberg, Carl [1 ]
Chapellier, Marion [1 ]
Shah, Mansi [2 ]
Nilsson, Bjorn [3 ]
Ebert, Benjamin L. [4 ]
Bhatia, Ravi [2 ]
Jaras, Marcus [1 ]
机构：
[1] Lund Univ, Div Clin Genet, Dept Lab Med, Lund, Sweden
[2] Univ Alabama Birmingham, Div Hematol Oncol, Birmingham, AL 35294 USA
[3] Lund Univ, Div Hematol & Transfus Med, Lund, Sweden
[4] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-116137
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
774
引用
收藏
页数：2
相关论文
共 50 条
  • [31] ABNORMAL INTRAGENIC TRANSCRIPTIONAL ACTIVATION IN MLL-AF9 AND KAT6A-CREBBP ACUTE MYELOID LEUKEMIA (AML)
    Marneth, A. E.
    Prange, K.
    Bergevoet, S. M.
    Obulkasim, A.
    Zwaan, C. M.
    Van den Heuvel-Eibrink, M. M.
    Haferlach, T.
    Fornerod, M.
    Jansen, J. H.
    Martens, J.
    Van der Reijden, B. A.
    HAEMATOLOGICA, 2016, 101 : 36 - 37
  • [32] Integrated transcriptomic and epigenetic data analysis identifiesaberrant expression of genes in acute myeloid leukemia with MLL-AF9 translocation
    Wang, Fangce
    Li, Zheng
    Wang, Guangming
    Tian, Xiaoxue
    Zhou, Jie
    Yu, Wenlei
    Fan, Zhuoyi
    Dong, Lin
    Lu, Jinyuan
    Xu, Jun
    Zhang, Wenjun
    Liang, Aibin
    MOLECULAR MEDICINE REPORTS, 2020, 21 (02) : 883 - 893
  • [33] CXCL12 promotes glycolytic reprogramming in acute myeloid leukemia cells via the CXCR4/mTOR axis
    M Braun
    M Qorraj
    M Büttner
    F A Klein
    D Saul
    M Aigner
    W Huber
    A Mackensen
    R Jitschin
    D Mougiakakos
    Leukemia, 2016, 30 : 1788 - 1792
  • [34] CXCL12 promotes glycolytic reprogramming in acute myeloid leukemia cells via the CXCR4/mTOR axis
    Braun, M.
    Qorraj, M.
    Buettner, M.
    Klein, F. A.
    Saul, D.
    Aigner, M.
    Huber, W.
    Mackensen, A.
    Jitschin, R.
    Mougiakakos, D.
    LEUKEMIA, 2016, 30 (08) : 1788 - 1792
  • [35] THE ESSENTIAL ROLE OF THE ENHANCERS OF POLYCOMB EPC1 AND EPC2 IN MLL-AF9 ACUTE MYELOID LEUKAEMIA IS A 'COMPLEX' STORY
    Mannion, N.
    Huang, X.
    HAEMATOLOGICA, 2017, 102 : 38 - 39
  • [36] Essential role of PR-domain protein MDS1-EVI1 in MLL-AF9 leukemia
    Zhang, Yi
    Owens, Kristina
    Hatem, Layla
    Glass, Carolyn H.
    Karuppaiah, Kannan
    Camargo, Fernando
    Perkins, Archibald S.
    BLOOD, 2013, 122 (16) : 2888 - 2892
  • [37] Conditional repression of the NRAS(G12V) expression causes apoptosis and remission of acute myeloid leukemia induced in cooperation with MLL-AF9
    Kim, Won-Il
    Matise, Ilze
    Diers, Miechaleen D.
    Largaespada, David A.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3530S - 3530S
  • [38] Combinations of Kinase Inhibitors May Be An Effective Therapeutic Strategy for Acute Myeloid Leukemia (AML) with MLL-AF9 Expression.
    Poire, Xavier
    Diaz-Flores, Ernesto
    Bergerson, Rachel Joy
    Sher, Dorie
    Odenike, Olatoyosi
    Shannon, Kevin
    Largaespada, David
    Stock, Wendy
    BLOOD, 2009, 114 (22) : 426 - 427
  • [39] Does the Chemotherapy Protocol Affect CXCL12/CXCR4 Axes in Acute Myeloid Leukemia Patients with Monocytic Differentiation?
    Yazdani, Bahar
    Mousavi, Zahra
    Ehsan, Mohsen
    Khandany, Kalantary
    Hassanshahi, Gholamhossein
    MIDDLE EAST JOURNAL OF CANCER, 2022, 13 (01) : 110 - 119
  • [40] RNA Binding Protein CELF2 Mutation Cooperates with MLL-AF9 in Driving Acute Myeloid Leukemia Development
    Wang, Xiaomin
    Guo, Tengxiao
    Wang, Yuxia
    Yuan, Shengnan
    Hou, Shuaibing
    Lan, Yanjie
    Yang, Shuang
    Yuan, Weiping
    BLOOD, 2020, 136
12345